Monitor for QLE's progress on financing, construction milestones at Pelindaba, and any further regulatory approvals from South African authorities. The binding framework with Necsa and existing TerraPower offtake reduce execution risk relative to a pure development-stage venture, but the company remains pre-revenue on enrichment.
Price Chart
Executive Summary
ASP Isotopes Inc. announced that its subsidiary, Quantum Leap Energy LLC (QLE), signed a binding Heads of Agreement with South Africa's Nuclear Energy Corporation (Necsa) to form a joint venture for commercial-scale HALEU production at Necsa's Pelindaba site. QLE will hold approximately 80% of the joint venture and lead operations, while Necsa contributes site access and regulatory support; offtake agreements with TerraPower are already in place. This is a significant commercial milestone for a development-stage nuclear fuels company, moving from MOU to binding framework with a state nuclear partner and a marquee customer.
Key Facts
- QLE signed a binding Heads of Agreement with Necsa for a joint venture to produce HALEU at Pelindaba, South Africa.
- QLE will hold approximately 80% ownership; Necsa will hold approximately 20%.
- Offtake agreements for the HALEU are already secured with TerraPower.
- QLE received approval from South Africa's Ministry of Electricity and Energy in July 2026 for uranium enrichment activities at Pelindaba.
- A test bench facility was previously constructed at Pelindaba; refurbishment of infrastructure is underway.
- The agreement builds on a November 2024 MOU and a February 2026 Pre-Implementation Services Contract.
Financial Impact
No financial terms disclosed; the joint venture is a development-stage project requiring capital arrangement by QLE.
Risk Factors
- QLE has not yet applied its enrichment technologies to U-235 or received regulatory approval to do so, except under the Necsa services contract.
- The joint venture requires significant capital; QLE's ability to arrange financing is unproven.
- South African regulatory, political, and operational risks associated with nuclear fuel production.
- Development-stage company with no current revenue from enrichment activities.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-422325 |
| Document: aspi-ex99_1.htm | 0001193125-26-422325 |
| Document: 0001193125-26-422325-index-headers.html | 0001193125-26-422325 |
| Document: 0001193125-26-422325-index.html | 0001193125-26-422325 |
| Document: 0001193125-26-422325.txt | 0001193125-26-422325 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | $2.07 | awaiting T+5 | — | $2.01 (−3.17%) |
Oct 15, 2026 11d ago | 8-K | $2.21 $2.09 | ▼ −5.43% | ▼ −4.42% | $2.01 (−9.28%) |
Oct 2, 2026 24d ago | 8-K | $2.91 $2.65 | ▼ −8.93% | ▼ −10.10% | $2.01 (−31.10%) |
Sep 25, 2026 4w ago | 144 | $2.60 $2.93 | ▲ +12.69% | ▲ +11.49% | $2.01 (−22.88%) |
Sep 9, 2026 6w ago | 425 | $3.82 $3.15 | ▼ −17.54% | ▼ −16.44% | $2.01 (−47.51%) |
Sep 2, 2026 7w ago | 144 | $3.90 $3.31 | ▼ −15.13% | ▼ −13.98% | $2.01 (−48.59%) |
Aug 20, 2026 9w ago | 425 / 8-K | $3.95 $4.04 | ▲ +2.41% | ▲ +1.29% | $2.01 (−49.18%) |
Aug 18, 2026 9w ago | 8-K | $3.86 $4.00 | ▲ +3.63% | ▲ +3.83% | $2.01 (−48.06%) |
Aug 16, 2026 10w ago | Institutional Cluster | $4.02 $3.89 | ▼ −3.23% | ▼ −2.04% | $2.01 (−50.12%) |
Aug 5, 2026 11w ago | 425 | $4.10 $4.28 | ▲ +4.39% | ▲ +3.18% | $2.01 (−51.10%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers